Mirae Asset Global Investments »

Halozyme Therapeutics shares owned by Mirae Asset Global Investments

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Mirae Asset Global Investments from 13F filings

Historical chart of Mirae Asset Global Investments investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Mirae Asset Global Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Mirae Asset Global Investments

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.2M 79k 40.68
2023-12-31 $2.8M 77k 36.96
2023-09-30 $2.9M 76k 38.20
2023-06-30 $2.7M 74k 36.07
2023-03-31 $3.0M 78k 38.19
2022-12-31 $3.7M 66k 56.90
2022-09-30 $2.6M 66k 39.55
2022-06-30 $2.2M 49k 44.01
2021-09-30 $329k 7.2k 45.39
2021-06-30 $329k 7.2k 45.39
2021-03-31 $307k 7.4k 41.67
2020-12-31 $384k 9.0k 42.72
2020-09-30 $225k 8.5k 26.41
2015-12-31 $1.8M 102k 17.34
2015-09-30 $949k 71k 13.43
2015-06-30 $819k 36k 22.61
2015-03-31 $986k 69k 14.29